AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21939972
Drug: Continuous lateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous lateral rotational therapy (CLRT) for 5 days
Trial: 22554721
Drug: Aspirin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (300 mg the night before surgery)
Trial: 17633371
Drug: Shenqi Fuzheng
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenqi Fuzheng Injection (SQFZI), 250 mL via intravenous dripping starting from 5 days before operation and after ending CPB once a day.
Trial: 9870832
Drug: Fluconazole 400
RxNorm normalized name: fluconazole 400 MG in 200 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 400 mg orally daily
Trial: 8205374
Drug: Flogan (potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flogan (potassium diclofenac suspension)
Trial: 8205374
Drug: Cataflam (potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cataflam (potassium diclofenac suspension)
Trial: 2488496
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D 4,000 IU per day
Trial: 2488496
Drug: Intramuscular injections
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injections of ergocalciferol 600,000 IU every six months
Trial: 2488496
Drug: Calcium intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium intake of at least 1 g per day
Trial: 2488496
Drug: Parenteral ergocalciferol
RxNorm normalized name: Ergocalciferol
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parenteral ergocalciferol
Trial: 1096276
Drug: Prenazone 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenazone 600 mg daily
Trial: 31286828
Drug: Combined (active
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined (active rTMS + fluoxetine)
Trial: 31286828
Drug: Placebo (sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sham rTMS + placebo fluoxetine)
Trial: 31286828
Drug: Fluoxetine (sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (sham rTMS + fluoxetine)
Trial: 25653511
Drug: Alfuzosin 10
RxNorm normalized name: Alfuzosin 10mg Oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfuzosin 10 mg monotherapy
Trial: 25653511
Drug: Alfuzosin 10
RxNorm normalized name: Alfuzosin 10mg Oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfuzosin 10 mg + antihypertensive combination therapy
Trial: 21046285
Drug: AMG 114
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 114 (15 μg)
Trial: 21046285
Drug: AMG 114
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 114 (50 μg)
Trial: 21046285
Drug: AMG 114
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 114 (200 μg)
Trial: 8641482
Drug: Gonadotropin-releasing hormone
RxNorm normalized name: Gonadotropin-releasing hormone
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gonadotropin-releasing hormone agonist (GnRH-a) and oral contraceptive (OC) therapy
Trial: 3902531
Drug: Naproxen 1000
RxNorm normalized name: naproxen 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 1000 mg once daily
Trial: 23219537
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg avanafil
Trial: 23219537
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg avanafil
Trial: 17007488
Drug: V.A.C. Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: V.A.C. Therapy
Trial: 10977030
Drug: Inhaled insulin
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled insulin powder (87.2 U)
Trial: 10977030
Drug: Subcutaneous insulin
RxNorm normalized name: subcutaneous insulin pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin (10.2 U)
Trial: 10977030
Drug: Intravenous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous insulin (5.5 U)
Trial: 8485067
Drug: Nicorandil 10
RxNorm normalized name: nicorandil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil 10 mg bid
Trial: 3959099
Drug: Ongoing daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing daily self-monitoring
Trial: 24311644
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) 1125 mg
Trial: 24311644
Drug: Pregabalin (PGB)
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin (PGB) 294 mg
Trial: 23892777
Drug: Varenicline (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (0.5 mg/day for first 3 days, then 1 mg/day for 4 days)
Trial: 21958943
Drug: E2/NETA (estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2/NETA (estradiol 2 mg/norethisterone acetate 1 mg)
Trial: 18434919
Drug: Fluoxetine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine treatment for pediatric major depressive disorder
Trial: 10717926
Drug: Vobenzim (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vobenzim (initial dose 18‐24 dragees, maintenance 12‐15 dragees a day)
Trial: 10717926
Drug: Pathogenetic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pathogenetic therapy only (Control)
Trial: 8263606
Drug: High fiber
RxNorm normalized name: High Fiber Gummies Soft Chew
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High fiber diet (31.3 g fiber/d, 586 mg calcium/d)
Trial: 8263606
Drug: Low fiber
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low fiber diet (6.5 g fiber/d, 530 mg calcium/d)
Trial: 3744131
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (5,000 antifactor Xa U/24 h)
Trial: 3744131
Drug: Low-dose conventional
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose conventional heparin (5,000 IU/12 h)
Trial: 24121658
Drug: G.O.A.L. intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G.O.A.L. intervention (90-min after-school physical activity club 4 days/week and one motivational interviewing session with a registered nurse)
Trial: 24121658
Drug: G.O.A.L. intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G.O.A.L. intervention
Trial: 15723201
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 100% tea tree oil (TTO)
Trial: 15723201
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 5% TTO lotion
Trial: 15723201
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of placebo lotion (no TTO)
Trial: 15723201
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 100% macadamia oil
Trial: 15723201
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 100% TTO
Trial: 11772797
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg midazolam syrup
Trial: 11772797
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg midazolam syrup
Trial: 11772797
Drug: 1.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg midazolam syrup
Trial: 11772797
Drug: 1.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg midazolam syrup (maximum 20 mg)
Trial: 11772797
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of midazolam syrup
Trial: 9674809
Drug: i.v. methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. methylprednisolone high dose
Trial: 9674809
Drug: i.v. methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. methylprednisolone low dose
Trial: 7988623
Drug: Azithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (500 mg + 250 mg) + Midazolam 10 mg
Trial: 7988623
Drug: Erythromycin 750
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin 750 mg (as a positive control)
Trial: 3052965
Drug: naproxen 10
RxNorm normalized name: naproxen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen 10 mg/kg/day
Trial: 3052965
Drug: tolmetin 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolmetin 25 mg/kg/day
Trial: 3052965
Drug: diclofenac 2
RxNorm normalized name: diclofenac 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac 2 mg/kg/day
Trial: 30384842
Drug: iv exenatide
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: iv exenatide (1‐h bolus of 0.05 µg min‐1 followed by a constant infusion of 0.025 µg min‐1)
Trial: 30384842
Drug: iv insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: iv insulin therapy (control group)
Trial: 24274806
Drug: Tailored interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tailored interventions (specific details on dosage and duration not provided)
Trial: 21673137
Drug: Pasireotide 450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 450 µg/d
Trial: 21673137
Drug: Pasireotide 900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 900 µg/d
Trial: 21673137
Drug: Pasireotide 1350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 1350 µg/d
Trial: 21673137
Drug: Pasireotide 1800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 1800 µg/d
Trial: 21673137
Drug: Pasireotide 2250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 2250 µg/d
Trial: 21673137
Drug: Pasireotide 2025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 2025 µg/d
Trial: 21673137
Drug: Pasireotide infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide infusion
Trial: 16113179
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg metoclopramide as a slow intravenous infusion over 15 minutes (SIG group)
Trial: 16113179
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg metoclopramide intravenous bolus infusion over two minutes (BIG group)
Trial: 12107041
Drug: Acamprosate plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acamprosate plus minimal intervention (3‐weekly sessions of 20 min)
Trial: 12107041
Drug: Acamprosate plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acamprosate plus brief cognitive behavioural therapy (7‐weekly sessions of 60 min)
Trial: 2129490
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg famotidine b.d.
Trial: 2129490
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg naproxen b.d. + 20 mg famotidine b.d.
Trial: 2129490
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg naproxen b.d. + 40 mg famotidine nocte
Trial: 2129490
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg naproxen b.d. + placebo
Trial: 6160364
Drug: Gamma Venin
RxNorm normalized name: Gamma Cyclodextrin
DrugBank: Gamma cyclodextrin (DB19173)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma Venin 10 g within the first 48 h after surgery
Trial: 31842966
Drug: Small stitches
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Small stitches closure followed by augmentation with a light-weight polypropylene mesh in the onlay technique
Trial: 27486122
Drug: Vitamin B12
RxNorm normalized name: Vitamin B12
DrugBank: Cyanocobalamin Co-57 (DB09385)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin B12 supplementation (2 RDAs daily for 6 months)
Trial: 27486122
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid supplementation (2 RDAs daily for 6 months)
Trial: 27486122
Drug: Both vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both vitamin B12 and folic acid supplementation (2 RDAs daily for 6 months)
Trial: 27486122
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (daily for 2 months)
Trial: 24994725
Drug: FRAX treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FRAX treatment criteria
Trial: 24994725
Drug: Osteoporosis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteoporosis treatment
Trial: 22611315
Drug: Small-volume epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Small-volume epinephrine (15 to 25 mL injection; Group 1, n = 50)
Trial: 22611315
Drug: Large-volume epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Large-volume epinephrine (30 to 40 mL injection; Group 2, n = 50)
Trial: 17541049
Drug: Duloxetine, 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine, 60 mg/day
Trial: 9846847
Drug: High oleate
RxNorm normalized name: oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High oleate meal (95 g fat)
Trial: 9846847
Drug: Low-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat meal (18 g MCT)
Trial: 7865062
Drug: 0.6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg/kg rocuronium (2 x ED 95)
Trial: 7865062
Drug: 0.06 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.06 mg/kg rocuronium as priming dose followed by 0.24 mg/kg intubating dose
Trial: 7865062
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (0.6 mg/kg and 0.06 mg/kg + 0.24 mg/kg)
Trial: 2690557
Drug: Adjuvant single-agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant single-agent doxorubicin
Trial: 30637662
Drug: 200 μg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 μg/day selenium supplements as selenium yeast (n=17)
Trial: 29774682
Drug: Flupentixol/Melitracen 10.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupentixol/Melitracen 10.5 mg, QD, treatment lasts 4 months
Trial: 29774682
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (specific immunotherapy only)
Trial: 29774682
Drug: Flupentixol/Melitracen combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupentixol/Melitracen combined with specific immunotherapy
Trial: 25917673
Drug: bivalent OPV
RxNorm normalized name: Opvee
DrugBank: Nalmefene (DB06230)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: bivalent OPV (bOPV) + inactivated polio vaccine (IPV)
Trial: 23452344
Drug: Deep neuromuscular
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep neuromuscular blockade (NMB) using high-dose rocuronium, reversed by 4 mg/kg sugammadex
Trial: 23452344
Drug: Moderate neuromuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate neuromuscular blockade (NMB) using a combination of atracurium and mivacurium, reversed by 1 mg neostigmine and 0.5 mg atropine
Trial: 17914039
Drug: Donepezil 10
RxNorm normalized name: donepezil 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 10 mg per day
Trial: 11510790
Drug: Conventional CPAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional CPAP therapy
Trial: 11510790
Drug: Auto CPAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auto CPAP therapy
Trial: 7646097
Drug: Completely heparin-coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Completely heparin-coated circuit with reduced heparin dose (activated clotting time > 250 seconds)
Trial: 15169793
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m²
Trial: 15169793
Drug: Paclitaxel 210
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 210 mg/m²
Trial: 15169793
Drug: Paclitaxel 250
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 250 mg/m²
Trial: 15169793
Drug: Paclitaxel (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (all doses)
Trial: 15169793
Drug: Paclitaxel (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (higher doses)
Trial: 9387047
Drug: Liposomally encapsulated
RxNorm normalized name: liposomal encapsulated paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Liposomally encapsulated daunorubicin (DaunoXome) at 120 mg/m2 repeated every 21 days
Trial: 9387047
Drug: Liposomally encapsulated
RxNorm normalized name: liposomal encapsulated paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Liposomally encapsulated daunorubicin (DaunoXome) at 40 mg/m2 repeated every 14 days
Trial: 8404181
Drug: Salt loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salt loading (+ 6.1 +/‐ 2.8 g NaCl/d = + 105 +/‐ 48 mmol Na)
Trial: 8404181
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate loading (+ 140 +/‐ 40 ml Shohl's solution, = + 120 +/‐ 30 mmol Na)
Trial: 8404181
Drug: Low-salt diet
RxNorm normalized name: Low-energy diets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-salt diet (5 to 6 g NaCl/d = 86 to 103 mmol Na)
Trial: 3528541
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg disulfiram
Trial: 3528541
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg disulfiram
Trial: 2645950
Drug: Repeated treatment
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated treatment with daunorubicin (DNR), vincristine (VCR), and cytosine arabinoside (ara‐C)
Trial: 2645950
Drug: Alternating treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating treatment with amsacrine (AMSA) combined with high dose ara‐C and 5-azacytidine
Trial: 2645950
Drug: Intensive combination
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive combination of high-dose ara‐C and AMSA
Trial: 21054754
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of udenafil given 1 h before TURP
Trial: 21054754
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of tadalafil given 1 h before TURP
Trial: 11465985
Drug: Systemic adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic adenosine infusion (50 microg/kg/min for 60 min)
Trial: 11465985
Drug: Systemic adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic adenosine infusion
Trial: 8276659
Drug: 5-fluorouracil, 450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil, 450 mg/m2 intravenously for 3 consecutive days during the first and last weeks of radiation therapy; Levamisole, 50 mg orally 3 times daily for 3 consecutive days concurrent with radiation therapy and 5-fluorouracil.
Trial: 4844514
Drug: Quingestanol acetate
RxNorm normalized name: quinestradol
DrugBank: Quingestanol acetate (DB14679)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quingestanol acetate (1.5 mg postcoital)
Trial: 4844514
Drug: d‐norgestrel (3.35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d‐norgestrel (3.35 mg postcoital)
Trial: 24888428
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis (rt-PA) for anterior circulation strokes in patients with LVO
Trial: 24888428
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis (rt-PA) for anterior circulation strokes in patients with No-LVO
Trial: 21691117
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (20 mg/kg/day for 3 weeks)
Trial: 9482363
Drug: Acetaminophen, aspirin,
RxNorm normalized name: Acetaminophen, Aspirin, and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen, aspirin, and caffeine combination